Literature DB >> 6694583

Carbamazepine--erythromycin-base interaction.

F J Vajda, P F Bladin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6694583     DOI： 10.5694/j.1326-5377.1984.tb103896.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

Review 1.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 2.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

3.  Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite.

Authors:  N Barzaghi; G Gatti; F Crema; M Monteleone; C Amione; L Leone; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.